Trial Profile
An open label, cross-over, randomised study to evaluate the bioequivalence and the effect of food on pharmacokinetics of vildagliptin/metformin fixed dose combination compared to free combinations in healthy Japanese subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin/metformin (Primary) ; Metformin; Vildagliptin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 11 Mar 2016 New trial record
- 02 Mar 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics